Your Ad Here

Thursday, May 10, 2007

Migraines Cost Business Big Bucks, Too


Migraines take a toll on employers as well — up to $28.7 billion in annual direct and indirect healthcare costs can be attributed to migraine-related losses in productivity. Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity. The data also suggested workers consider potential treatment options that may help them prevent or reduce the frequency of migraine attacks.

The first of three analyses sponsored by Ortho-McNeil Neurologics, Inc. found that employers who actively screen for migraine may help identify those undiagnosed with the condition. The researchers also evaluated the total burden of migraine in the workplace and found that more than 50 percent of the migraine sufferers surveyed experienced moderate to severe disability due to the condition, often affecting job performance and leading to missed workdays. The third analysis examined the impact of preventive treatment on workers who suffer from frequent migraines and suggested that use of TOPAMAX (topiramate) may lead to fewer missed workdays and improve workplace productivity.

"Migraine can have a significant impact in the workplace," says study investigator Jennifer Lofland, project director, Department of Health Policy, Jefferson Medical College of Thomas Jefferson University.

"If migraine can be effectively managed during the workday, it may lead to cost savings for employers over the long run. One approach patients may want to consider is taking a preventive medication to help reduce the frequency of migraine attacks and potentially lead to more migraine-free days."


Bookmark http://universeeverything.blogspot.com/ and drop back in sometime.

Labels: , , , , , , ,

Thursday, May 03, 2007

Common Pain Medications Do Not Prevent Alzheimer's

Over-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's disease, according to a study published April 25, in the online edition of Neurology, the scientific journal of the American Academy of Neurology. These findings appear to contradict earlier observational studies, which found sustained use of nonsteroidal anti-inflammatory drugs (NSAIDs) may have a protective effect against Alzheimer's disease.

The clinical trial, conducted at six dementia research clinics across the United States, involved more than 2,100 people over age 70 with no signs of dementia, but a family history of Alzheimer's disease. The participants were randomly assigned daily doses of naproxen, celecoxib, or placebo for up to four years, but most participants had received the treatments for less than two years.

The study found neither treatment was associated with a reduction in Alzheimer's disease or dementia.

"Although our study was conducted to test the hypothesis that celecoxib or naproxen would reduce the incidence of Alzheimer's disease, these results indicate no such effect, at least within the first few years after treatment begins," says study author Constantine Lyketsos, MD, MHS, with Johns Hopkins Bayview Hospital and Johns Hopkins School of Medicine in Baltimore, Maryland.

The findings appear to be inconsistent with other studies suggesting reduced risk of Alzheimer's disease among people who take NSAIDs over a long period of time. "One possible explanation for this inconsistency is that our findings relate specifically to celecoxib and naproxen, but not to other commonly used NSAIDs, such as ibuprofen. Or the drugs may not prevent the progression of disease in people who have advanced Alzheimer's pathology without symptoms – the very people most likely to develop symptoms within a year or two," says study author John Breitner, MD, with VA Puget Sound Health Care.

"While long-term follow-up of our study's participants is essential, for now we suggest celecoxib and naproxen not be taken to primarily prevent Alzheimer's disease," says Lyketsos.


Bookmark http://universeeverything.blogspot.com/ and drop back in sometime.

Labels: , , , , , , ,